Literature DB >> 21328376

Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan.

Anis Khan1, Yasuhito Tanaka, Fuat Kurbanov, Abeer Elkady, Zaigham Abbas, Zahid Azam, Amna Subhan, Sajjad Raza, Sajjad Razza, Saeed Hamid, Wasim Jafri, James Shih, Ningshao Xia, Kazuaki Takahashi, Shunji Mishiro, Masashi Mizokami.   

Abstract

Hepatitis E is a classic water-borne disease in developing countries. Detection of anti-HEV IgM and IgG antibodies, in addition to HEV RNA are useful epidemiological markers in diagnosis of hepatitis E. This study was conducted to investigate an outbreak of acute viral hepatitis in South-Pakistan. Anti-HEV IgM and IgG were assessed comparatively with serological kits manufactured by Abbott, Cosmic, TGH, and Wantai, selecting HEV RNA as reference assay. Molecular evolutionary analysis was performed by phylogeny and HEV spread time analysis by Bayesian Coalescent Theory approach. Of the 89 patients, 24 (26.9%) did not have acute hepatitis viral marker. Of the remaining 65 cases, 4 (6.1%) were positive for anti-HAV IgM, one (1.5%) for anti-HBc IgM, 2 (3%) for HCV, 53 (81.5%) for anti-HEV IgM, and 5 (7.7%) were hepatitis-negative. The Wantai test was 100% sensitive and specific followed by Cosmic (98.1% and 100%), TGH (98.1% and 97.2%) and Abbott (79.2% and 83.3%). Two HEV variant strains were detected by phylogeny responsible for this acute hepatitis outbreak. Estimates on demographic history of HEV showed that HEV in Pakistan has remained at a steady nonexpanding phase from around 1970 to the year 2005, in which it expanded explosively with the emergence of new HEV variants. In conclusion, the limited sensitivity of available assay (Abbott anti-HEV EIA) may be a concern in HEV diagnosis in Pakistan. This study cautions that the dissemination of the variant strains to other areas of Pakistan may lead to explosive HEV outbreaks.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328376     DOI: 10.1002/jmv.22036

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010-2012.

Authors:  Gemechu B Gerbi; Roxanne Williams; Barnabas Bakamutumaho; Stephen Liu; Robert Downing; Jan Drobeniuc; Saleem Kamili; Fujie Xu; Scott D Holmberg; Eyasu H Teshale
Journal:  Am J Trop Med Hyg       Date:  2014-12-01       Impact factor: 2.345

3.  Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays.

Authors:  Hyun Kyung Park; Sook-Hyang Jeong; Jin-Wook Kim; Byung-Hyun Woo; Dong Ho Lee; Hyun Young Kim; Soyeon Ahn
Journal:  BMC Infect Dis       Date:  2012-06-22       Impact factor: 3.090

4.  Hepatitis E seroprevalence among blood donors: A pilot study from Western India.

Authors:  Maitrey D Gajjar; Nidhi M Bhatnagar; Rajesh V Sonani; Shweta Gupta; Tarak Patel
Journal:  Asian J Transfus Sci       Date:  2014-01

5.  A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.

Authors:  Yuki Inagaki; Yukio Oshiro; Tomohiro Tanaka; Tomoharu Yoshizumi; Hideaki Okajima; Kohei Ishiyama; Chikashi Nakanishi; Masaaki Hidaka; Hiroshi Wada; Taizo Hibi; Kosei Takagi; Masaki Honda; Kaori Kuramitsu; Hideaki Tanaka; Taiji Tohyama; Toshihiko Ikegami; Satoru Imura; Tsuyoshi Shimamura; Yoshimi Nakayama; Taizen Urahashi; Kazumasa Yamagishi; Hiroshi Ohnishi; Shigeo Nagashima; Masaharu Takahashi; Ken Shirabe; Norihiro Kokudo; Hiroaki Okamoto; Nobuhiro Ohkohchi
Journal:  EBioMedicine       Date:  2015-11       Impact factor: 8.143

Review 6.  Hepatitis E infection among Ghanaians: a systematic review.

Authors:  Richard Ofori-Asenso; Akosua Adom Agyeman
Journal:  Infect Dis Poverty       Date:  2017-02-06       Impact factor: 4.520

Review 7.  Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants.

Authors:  Essam M Janahi; Saba F D Parkar; Sakina Mustafa; Zaki M Eisa
Journal:  Medicina (Kaunas)       Date:  2020-04-25       Impact factor: 2.430

8.  Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study.

Authors:  Piyawat Komolmit; Vinita Oranrap; Sirinporn Suksawatamnuay; Kessarin Thanapirom; Supachaya Sriphoosanaphan; Nunthiya Srisoonthorn; Nawarat Posuwan; Thanunrat Thongmee; Sombat Treeprasertsuk; Yong Poovorawan
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

Review 9.  Viral Hepatitis in Pakistan: Past, Present, and Future.

Authors:  Amna Subhan Butt; Fatima Sharif
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.